Archive for September, 2010

0
10
Sep

9 Year Old Child Loses Mother in Boat Accident

The Houston Chronicle reported a fatal boat accident that took place at Clear Creek Nature Park earlier this week. One person was killed and two others were hospitalized. Details suggest that the boat, being driven by James Doug Pitcock Jr., lost control while trying to execute a turn.

As of now the cause of the accident is still under investigation, and there is no reason to assume that driver inattentiveness or impairment were partially to blame. It does, however, bring to light the fact that while distracted driving of automobiles has become a nation wide safety issue, distracted or impaired driving of other vehicles or boats is just as dangerous.

The US Coast Guard reported 2,815 boating accidents in 2009. The number one cause of these accidents was driver inattention. Also among the list of causes were: operator inexperience, excessive speed, alcohol impairment, and following the“rules of the road”. These are the same factors that cause motor vehicle accidents every single day.

The National Highway Traffic Safety Administration is working hard to end distracted driving on our nation’s roadways. However, there is very little focus being devoted to distracted driving of other vehicles or boats.

Distracted driving comes in many forms and the things that distract us while driving an automobile can also distract us while operating a boat or other type of vehicle. These distractions can include talking on a cell phone, texting, adjusting the GPS, eating, drinking, applying makeup, and even smoking can take a drivers eyes off the road, or water, for even a second. This is all the time it takes for a serious accident to occur.

We don’t know if distraction played a role in the afore mentioned boating accident. But we do know that a young boy has lost his mother in what was most likely an avoidable tragedy and unfortunately it sometimes takes a lost life like this to create greater awareness of the huge responsibility we take when we get behind the wheel of any type of vehicle.

Popularity: 12% [?]

0
3
Sep

Meridia: “Another Flawed Diet Pill” Or Successful Weight Loss Drug?

The executive editor of The New England Journal of Medicine has taken a strong position by calling Abbott Laboratories weight loss drug Meridia “another flawed diet pill.” The pill has come under significant scrutiny and will be reviewed by an FDA panel on
September 15th.

According to a company-sponsored study people who take Meridia have a slightly higher risk of a nonfatal heart attack or stroke. However, this increased risk has only been seen in patients that have some form of heart disease. Therefore, the company is intent on keeping the drug on the market but restricting it to patients that do not have any known heart problems.

The strategy was not accepted in Europe and the diet pill has been banned there. If the editors at The New England Journal of Medicine have their way, it will also be banned in the US. They contend that the risk far outweighs any benefit. Furthermore, they question if there is any real benefit at all by noting that in most instances the weight loss evidenced by patients on the drug, is generally no more than 9 pounds, or less than 5% of the body weight.

Why would a company accept such a risk by keeping the drug on the market? We don’t purport to know that, however we do know that in the pharmaceutical industry, obesity is known as the “trillion dollar disease” and that is the estimated amount of profit that could be made by a manufacturer that is able to produce a drug that is both safe and effective in treating obesity.

So far, no company has successfully done so. Currently the only other FDA approved drug for long term treatment of obesity is Xenical. However, there are two other drugs currently awaiting FDA approval. They are Contrave from Orexigen Therapeutics Inc and Lorcaserin from Arena Pharmaceuticals.

Considering the financial potential for a successful obesity drug, it is no surprise that Abbott, a big pharma company, is fighting for the right to keep Meridia on the market. As defective drug attorneys it is also no surprise to us that a big pharma company is willing to accept a very significant level of risk when the financial potential is so strong.

References:

http://www.nejm.org/doi/full/10.1056/NEJMoa1003114

http://www.realdietmeds.com/blog/

http://www.healthnews.com/nutrition-diet/weight-loss/weight-loss-drug-meridia-comes-under-fireagain-4442.html

http://www.webmd.com/diet/news/20100901/weight-loss-pill-meridia-ups-heart-attack-stroke

Popularity: 17% [?]